A detailed history of Blue Owl Capital Holdings LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 3,004,199 shares of PLRX stock, worth $39.7 Million. This represents 11.1% of its overall portfolio holdings.

Number of Shares
3,004,199
Previous 3,004,199 -0.0%
Holding current value
$39.7 Million
Previous $32.3 Million 4.28%
% of portfolio
11.1%
Previous 13.41%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$12.85 - $19.15 $38.6 Million - $57.5 Million
3,004,199 New
3,004,199 $54.4 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $643M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Blue Owl Capital Holdings LP Portfolio

Follow Blue Owl Capital Holdings LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Owl Capital Holdings LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Owl Capital Holdings LP with notifications on news.